Mitocholine
The Future of Cognitive Wellness

In the quest for cognitive wellness, unlocking the full potential of the human brain is a persistent endeavor. This becomes crucial when faced with the inevitability of aging, which introduces a gradual cognitive decline due to slowing of brain metabolism. This results in reduced energy levels in the brain, impairing cognition and increasing the likelihood of neurodegenerative disorders.

Mitocholine, an innovative biotechnology firm, is set to elevate expectations for cognitive health through groundbreaking research. It is bringing to market an innovative nutritional composition of natural human metabolites and mitochondrial substrates designed for daily consumption to enhance cognitive function.

Working in synergy, this combination of dicholine succinate, a mitochondrial complex II substrate, and nicotinamide, a form of Vitamin B3, effectively penetrates the formidable blood-brain barrier and targets cellular mitochondria to increase the production of adenosine triphosphate (ATP), the energy molecule. The goal is to enhance mitochondrial function in the brain, but also other parts of the body, to address aging-related challenges.

“Our breakthrough composition works in synergy to optimize energy production in cells through the glucose utilization pathway and promote metabolic insulin receptivity to prevent cognitive decline in the aging process,” says Larisa Andreeva, founder and CEO of Mitocholine.

Mitocholine stands apart with its approach that uses multiple pathways for energy optimization through a nutritional solution that increases energy uptake and optimizesglucose utilization in brain cells.

It addresses mitochondrial dysfunction, a hallmark of diseases associated with aging. It remedies reduced ATP production in cells, which also affects age-related muscle frailty known as sarcopenia, and chronic liver diseases. It leverages the cellular process of oxidative phosphorylation within mitochondria, which revolves around stimulating the electronic transfer chain to channel electrons to generate ATP.

In a distinct approach, Mitocholine combines the substrates for complex one and complex two of electron transport chains in the glucose pathway. The nutritional solution contains nicotinamide, a substrate for complex one, with dicholine succinate, which is a substrate for complex two with essential nutrient choline. They work synergistically together to elevate ATP levels within the cellular energy-producing machinery six times more effectively than any component on its own.

In addition to optimizing the glucose utilization pathway, Mitocholine addresses metabolic insulin resistance, often linked with aging. As the body’s insulin response declines with age and fails to produce enough energy, the combination of salts in the nutritional solution acts as a sensitizer of insulin receptors at the cellular level. It delivers signals to the insulin receptor for phosphorylation to improve the brain’s insulin responsiveness.

These results emphasize the composition’s favorable effects on cognitive function and energy metabolism, endorsing its potential to contribute to overall well-being when incorporated into a standard dietary routine.

Mitocholine is currently conducting a clinical trial on individuals with mild cognitive decline to assess the impact on executive function and homocysteine levels, as homocysteine is a risk factor for cognitive impairment. Another trial is underway in healthy subjects to show its ability to improve energy levels and exercise capacity during exercise to prove benefits in skeletal muscle promotion and general fitness.

As further studies and applications advance, Mitocholine is poised to usher in a new era of cognitive wellness and enhanced overall health through its ready-to use nutritional solution.